Stockscreener 앱 받기
73.94
1.23%
0.90
전일 마감가:
$73.04
열려 있는:
$72.74
하루 거래량:
1.20M
Relative Volume:
0.90
시가총액:
$8.48B
수익:
$13.18B
순이익/손실:
$419.00M
주가수익비율:
22.61
EPS:
3.2704
순현금흐름:
$521.00M
1주 성능:
+0.31%
1개월 성능:
-9.13%
6개월 성능:
+11.98%
1년 성능:
+6.77%
1일 변동 폭
$71.31
$75.10
1주일 범위
$71.31
$75.10
52주 변동 폭
$60.56
$89.29
헨리 샤인 Stock (HSIC) Company Profile
명칭
Henry Schein Inc
전화
(631) 843-5500
주소
135 DURYEA RD, MELVILLE, NY
Compare HSIC vs MCK, COR, CAH, AHG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
73.94 | 8.48B | 13.18B | 419.00M | 521.00M | 3.2704 |
MCK
Mckesson Corporation
|
884.28 | 108.31B | 397.96B | 4.55B | 9.64B | 34.77 |
COR
Cencora Inc
|
324.80 | 63.18B | 325.78B | 1.64B | 3.61B | 8.3139 |
CAH
Cardinal Health Inc
|
214.05 | 50.37B | 244.67B | 1.68B | 5.51B | 6.9487 |
AHG
Akso Health Group Adr
|
2.22 | 1.90B | 14.85M | -136.07M | 7.23M | -0.4726 |
헨리 샤인 Stock (HSIC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-23 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-08-26 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-07-25 | 다운그레이드 | Stifel | Buy → Hold |
| 2025-07-14 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-02-14 | 개시 | Wells Fargo | Equal Weight |
| 2025-01-06 | 업그레이드 | BofA Securities | Underperform → Buy |
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-07-22 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2023-12-12 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-11-10 | 업그레이드 | Stifel | Hold → Buy |
| 2022-08-08 | 업그레이드 | UBS | Sell → Neutral |
| 2022-07-21 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-06-14 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2022-05-13 | 재개 | Credit Suisse | Outperform |
| 2022-01-31 | 개시 | Morgan Stanley | Underweight |
| 2022-01-07 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2021-10-01 | 재개 | Credit Suisse | Neutral |
| 2021-02-08 | 재개 | Piper Sandler | Overweight |
| 2021-01-04 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2020-11-03 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2020-04-07 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-04-02 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-01-09 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2020-01-02 | 업그레이드 | Evercore ISI | Underperform → In-line |
| 2019-08-07 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2019-05-30 | 개시 | Wolfe Research | Underperform |
| 2019-05-15 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2019-04-18 | 개시 | Guggenheim | Buy |
| 2019-01-17 | 개시 | UBS | Sell |
| 2019-01-03 | 다운그레이드 | Evercore ISI | In-line → Underperform |
| 2019-01-02 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2018-11-08 | 재확인 | Barrington Research | Outperform |
| 2018-10-25 | 다운그레이드 | Edward Jones | Hold → Sell |
| 2018-10-19 | 재개 | Goldman | Neutral |
| 2018-10-04 | 재확인 | Robert W. Baird | Outperform |
| 2018-08-07 | 재확인 | Stifel | Hold |
| 2018-04-24 | 다운그레이드 | Goldman | Buy → Neutral |
| 2018-04-04 | 업그레이드 | Leerink Partners | Mkt Perform → Outperform |
모두보기
헨리 샤인 주식(HSIC)의 최신 뉴스
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Entry Recap: Is Henry Schein Inc still a buy after recent gainsTrade Ideas & Low Risk Entry Point Tips - baoquankhu1.vn
Henry Schein (HSIC) price target increased by 12.37% to 90.80 - MSN
Henry Schein (HSIC) down 9.4% since last earnings report: Can it rebound? - MSN
Henry Schein Inc. stock rises Tuesday, still underperforms market - MarketWatch
Henry Schein Inc Stock: A Steady Force in Dental and Medical Distribution for North American Investo - AD HOC NEWS
Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Henry Schein (HSIC), Encompass Health (EHC) and Merck & Company (MRK) - The Globe and Mail
Henry Schein: A Cash-Generating Healthcare Distributor Priced for Mediocrity - TradingView
Henry Schein, Inc. (NASDAQ:HSIC) Short Interest Update - MarketBeat
Assenagon Asset Management S.A. Buys 45,701 Shares of Henry Schein, Inc. $HSIC - MarketBeat
Henry Schein stock drops 2.18% as company recognized among World’s Most Ethical Companies - Traders Union
Henry Schein Inc Stock: A Steady Force in Dental and Medical Distribution for Long-Term Investors - AD HOC NEWS
Henry Schein stock hits 52-week highhere's why - msn.com
Henry Schein Inc. stock underperforms Friday when compared to competitors - MarketWatch
Vanguard Reports 0 Shares in Henry Schein After Realignment (NASDAQ: HSIC) - Stock Titan
Henry Schein One Drives Growth with Cloud-Based Dental Solutions and AI Integration - Bitget
Henry Schein (HSIC) Down 9.4% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Should You Keep Henry Schein Shares in Your Investment Portfolio at This Time? - Bitget
Should You Retain Henry Schein Stock in Your Portfolio for Now? - Yahoo Finance
How Investors May Respond To Henry Schein (HSIC) Strong Q4 Specialty Products-Driven Margin Expansion - Sahm
Henry Schein (HSIC) Goldman Sachs 45th Annual Global Healthcare Conference Summary - Quartr
How Surging Global Specialty Sales At Henry Schein (HSIC) Have Changed Its Investment Story - Yahoo Finance
Henry Schein, Inc. $HSIC Shares Purchased by SG Americas Securities LLC - MarketBeat
Henry Schein, Vir Biotechnology, Ultra Clean Holdings and other big stocks moving higher on Tuesday - MSN
Henry Schein stock faces uncertain trading amid lack of fresh catalysts in dental distribution secto - AD HOC NEWS
Is Henry Schein Stock Underperforming the S&P 500? - Barchart
This Henry Schein analyst turns bullish; here are top 3 upgrades for Monday - MSN
Push Button Handpiece Conversion Midwest 380420 Low Speed AdapterHenry Schein Dental Push Button Starter Kit - hotelier.com.py
Tudor Investment Corp ET AL Invests $15.38 Million in Henry Schein, Inc. $HSIC - MarketBeat
Henry Schein Q4 2025 earnings preview - MSN
Decliners Report: Will Henry Schein Inc face regulatory challengesWeekly Market Summary & Growth Oriented Trading Recommendations - baoquankhu1.vn
Barclays Sticks to Their Buy Rating for Henry Schein (HSIC) - The Globe and Mail
Top Henry Schein Executive Makes Notable Insider Stock Move - TipRanks
Henry Schein (NASDAQ:HSIC) CEO Thomas Popeck Sells 1,355 Shares - MarketBeat
Insider Sell: Thomas Popeck Sells Shares of Henry Schein Inc (HS - gurufocus.com
Charisma 66000085 Universal CompositeHenry Schein Dental - hotelier.com.py
Henry Schein CEO Popeck sells $98,630 in stock - Investing.com
Henry Schein CEO Popeck sells $98,630 in stock By Investing.com - Investing.com Australia
Henry Schein (HSIC) products CEO sells 1,355 shares in open-market trade - Stock Titan
3M Scotchbond 7423 Etchant Etching GelHenry Schein Dental - hotelier.com.py
Here's why Henry Schein (HSIC) is a strong growth stock - MSN
HSIC (NASDAQ) Form 144: insiders list 144, 191, 1,020 shares tied to vesting - Stock Titan
Zacks Research Has Negative View of Henry Schein Q1 Earnings - MarketBeat
Here's why Henry Schein (HSIC) is a strong value stock - MSN
Henry Schein Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Henry Schein secures Ethisphere World Most Ethical Companies recognition for 15th consecutive year - Traders Union
Henry Schein Named Among World’s Most Ethical Companies - Dentistry Today
Ethisphere Names Henry Schein as One of the 2026 World's Most Ethical Companies(R) for 15th Consecutive Year - MarketScreener
Here's Why Henry Schein (HSIC) is a Strong Growth Stock - Yahoo Finance
헨리 샤인 (HSIC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.31%
6.05%
자본화:
|
볼륨(24시간):